We are disappointed by the company’s weak Q3 revenue forecast. We have a neutral rating on the stock with a target price of Rs 380. The consulting segment is bearing the brunt of economic slowdown. Things are not looking good, at least in the near term. We have a neutral call on the stock with a target of Rs 420. We remain Underweight as we continue to expect margin and revenue headwinds. Weak momentum for Q3 with margin pressures persisting as environment worsens. We have an underweight call on the stock with a target price of Rs 360. The firm has cut FY23 EPS estimates by 4 percent and FY24 EPS estimates by 1 percent. Q2 numbers were in line with a modest growth outlook but valuations are supportive for the stock. We have an outperform rating on the stock with a target price of Rs 450. We cut FY23-24 EPS (earnings per share) estimates by 3-5 percent. Guidance for Q3 is disappointing and alludes to slowdown. Investors need to brace for near-term weakness as margin recovery is likely to be gradual.
STOCKS IN NEWS MONEYCONTROL SERIES
Interview Series Business In The Week Ahead.Pre-provision operating profit for the quarter increased by 69 percent to Rs 1,168.7 crore and other income (non-interest income) rose by 36 percent to Rs 1,061.3 crore compared to corresponding period last fiscal. Octo07:25 PM IST IDFC First Bank shares gain 4% in Muhurat trade after earnings beat estimates.
STOCKS IN NEWS MONEYCONTROL SOFTWARE
ICICI Securities, while maintaining its ‘buy’ stance, said growth in options, stable futures volumes and reduction in software cost post migration to new platform set up good prospects for FY24. Octo09:48 AM IST MCX shares zoom 6% on super show in second quarter.Octo10:23 AM IST JSW Steel climbs 4% as company sticks to FY23 volume guidance despite Q2 lossĪ sharp drop in steel prices, higher power and fuel costs and decline in realizations impacted the company's profitability in the Septemeber quarter.Octo12:42 PM IST Nykaa shares sink below issue price as end of lock-in period gets near.The pharmaceutical company reported a 20 percent year-on-year decline in profit at Rs 241.2 crore for quarter ended September FY23 Octo09:43 AM IST Gland Pharma hits 52-week low on disappointing Q2, brokerages cut price target.Through the Badshah acquisition, Dabur has entered into the Rs 25,000 crore spices and seasoning market in India Octo10:39 AM IST Dabur stock price rises on market share gain, Badshah acquisition.The company recently appointed a new CEO and MD and analysts advise caution till the transition phase is over Octo12:49 PM IST RBL Bank Q2: Investors impressed, analysts not.Octo03:32 PM IST DreamFolks shares soar as record travellers queue up at busy airports for lounge accessĪfter forming a Tweezer bottom candlestick pattern, a bullish reversal sign, the stock has rallied 17 percent from the Rs 364 support and has been making higher highs and higher lows since the first week of this month.
0 kommentar(er)
